rewrite this paragraph but keep data: Primary Outcomes There was no statistically significant difference in mSOFA scores between placebo and the vitamin C-infused patients from enrollment to 96 hours (Figure 2). The mean mSOFA score from baseline to 96 hours decreased from 9.8 to 6.8 in the vitamin C group (3 points) and from 10.3 to 6.8 in the placebo group (3.5 points) (difference, -0.10; 95% CI, 1.23 to 1.03; P = .86). There were no significant differences between the vitamin C group and placebo group in the C-reactive protein levels (54.1 vs 46.1 g/mL; difference, No. of patients Vitamin C 84 80 81 Placebo 83 73 67 Hours After Infusion 0 48 96 168 Hours After Infusion 75 80 73 47 82 69 63 49 vitamin C vs 29 M for placebo [12-39], P < .002). After cessation of vitamin C infusion, plasma levels in the vitamin C cohort decreased below 100 M but remained significantly higher than plasma ascorbate levels in placebo patients. B, There was no difference in the initial modified Sequential Organ Failure Assessment (mSOFA) scores of the 2 groups at baseline (vitamin C vs placebo, median, 10 [IQR, 7-12] vs 10 M [8-12]). During the